Centiva Capital, LP Procept Bio Robotics Corp Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Centiva Capital, LP holds 7,550 shares of PRCT stock, worth $648,620. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,550Holding current value
$648,620% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
260Shares Held
38.1MCall Options Held
245KPut Options Held
223K-
Vanguard Group Inc Valley Forge, PA4.84MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$299 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$132 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$107 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$101 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.83B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...